BIOCEPT INC (BIOC) Stock Analyst Ratings
NASDAQ:BIOC - Nasdaq - US09072V6002 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to BIOC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 838.15% above the current price.
BIOC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BIOC.
In the previous month the buy percentage consensus was at a similar level.
BIOC was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-04-14 | Maxim Group | Downgrade | Buy -> Hold |